Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | 0.00% | -1.80% | -11.02% |
May. 16 | HCW Biologics Inc. announced that it expects to receive $10 million in funding | CI |
May. 15 | HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 1.13M | Sales 2025 * | - | Capitalization | 41.23M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -29M | EV / Sales 2024 * | 36.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.76
x | P/E ratio 2025 * |
-1.98
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.7% |
1 week | -1.80% | ||
1 month | -18.05% | ||
3 months | -28.76% | ||
6 months | -4.39% | ||
Current year | -11.02% |
Managers | Title | Age | Since |
---|---|---|---|
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rebecca Byam
DFI | Director of Finance/CFO | 68 | 19-09-30 |
Peter Rhode
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Garrett
CHM | Chairman | 74 | 21-04-30 |
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rick Greene
BRD | Director/Board Member | 59 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 1.09 | 0.00% | 3,082 |
24-05-31 | 1.09 | 0.00% | 4,429 |
24-05-30 | 1.09 | -0.91% | 20,957 |
24-05-29 | 1.1 | 0.00% | 28,347 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.02% | 41.23M | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- HCWB Stock